Efficacy and tolerance evaluation of an ambulatory use of sacubitril/valsartan among patients with heart failure due to reduced ejection fraction

ConclusionWe observed a significant improvement in functional and echographic parameters among ambulatory patients with HFrEF after introduction of LCZ696. These results were obtained at the cost of a close monitoring to detect and manage side-effects, especially biological side effects.
Source: Archives of Cardiovascular Diseases Supplements - Category: Cardiology Source Type: research